YU36509B - Process for obtaining aryl substituted piperazinylalkylamino-uraci, - uracilethers and - uracilthioethers - Google Patents

Process for obtaining aryl substituted piperazinylalkylamino-uraci, - uracilethers and - uracilthioethers

Info

Publication number
YU36509B
YU36509B YU02076/70A YU207670A YU36509B YU 36509 B YU36509 B YU 36509B YU 02076/70 A YU02076/70 A YU 02076/70A YU 207670 A YU207670 A YU 207670A YU 36509 B YU36509 B YU 36509B
Authority
YU
Yugoslavia
Prior art keywords
uracilthioethers
uracilethers
piperazinylalkylamino
uraci
aryl substituted
Prior art date
Application number
YU02076/70A
Other languages
English (en)
Other versions
YU207670A (en
Inventor
Prusse Wolfgang
Wolfgang Prusse
Klemm Kurt
Kurt Klemm
Schoetensack Wolfgang
Wolfgang Schoetensack
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of YU207670A publication Critical patent/YU207670A/xx
Publication of YU36509B publication Critical patent/YU36509B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Communication Cables (AREA)
YU02076/70A 1969-08-20 1970-08-14 Process for obtaining aryl substituted piperazinylalkylamino-uraci, - uracilethers and - uracilthioethers YU36509B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1942405A DE1942405C3 (de) 1969-08-20 1969-08-20 Arylsubstituierte Piperazinylpropylenaminouracile

Publications (2)

Publication Number Publication Date
YU207670A YU207670A (en) 1982-02-25
YU36509B true YU36509B (en) 1984-02-29

Family

ID=5743321

Family Applications (2)

Application Number Title Priority Date Filing Date
YU02076/70A YU36509B (en) 1969-08-20 1970-08-14 Process for obtaining aryl substituted piperazinylalkylamino-uraci, - uracilethers and - uracilthioethers
YU02039/79A YU36518B (en) 1969-08-20 1979-08-20 Prcess for obtaining aryl-substituted piperazinylalkylamino-uracils, - uracilethers and - uracilthioethers

Family Applications After (1)

Application Number Title Priority Date Filing Date
YU02039/79A YU36518B (en) 1969-08-20 1979-08-20 Prcess for obtaining aryl-substituted piperazinylalkylamino-uracils, - uracilethers and - uracilthioethers

Country Status (24)

Country Link
US (2) US3957786A (no)
AT (2) AT302359B (no)
BE (1) BE755015A (no)
BG (3) BG17796A3 (no)
BR (1) BR6915466D0 (no)
CA (1) CA956944A (no)
CH (2) CH551990A (no)
DE (1) DE1942405C3 (no)
DK (1) DK124031B (no)
ES (1) ES382842A1 (no)
FI (1) FI54479C (no)
FR (1) FR2073300B1 (no)
GB (1) GB1309324A (no)
HK (1) HK23678A (no)
HU (1) HU163664B (no)
IE (1) IE35177B1 (no)
IL (1) IL35121A (no)
LU (1) LU61527A1 (no)
NL (1) NL155014B (no)
NO (1) NO129148B (no)
SE (1) SE386448B (no)
SU (1) SU399130A3 (no)
YU (2) YU36509B (no)
ZA (1) ZA705729B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2329399A1 (de) * 1973-06-08 1975-01-02 Wuelfing J A Fa 4-alkyl-aminouracile, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
LU74319A1 (no) * 1976-02-09 1977-08-19
DE3326118A1 (de) 1982-08-02 1984-02-09 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Pyridopyrimidintrione, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel
IE62890B1 (en) * 1988-12-06 1995-03-08 Hafslund Nycomed Pharma New piperazinylalkyl-3(2h)-pyridazinones process for the preparation thereof and the use thereof as agents lowering blood pressure
JPH078795B2 (ja) * 1989-09-06 1995-02-01 日立化成工業株式会社 排尿障害治療剤
EP0513058A1 (de) * 1990-02-01 1992-11-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Verwendung von bekannte uracile zur herstellung von arzneimittel für die verhütungen und behandlung von krankheitszusännden, die auf proliferativen prozessen beruhen.
DE4425143A1 (de) * 1994-07-15 1996-01-18 Basf Ag Substituierte Pyrimidinverbindungen und deren Verwendung
DE59509727D1 (de) * 1994-12-07 2001-11-22 Byk Gulden Lomberg Chem Fab Uracilderivate
EP1891954A3 (en) 1998-09-30 2009-01-14 Takeda Pharmaceutical Company Limited Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
AU2002230411A1 (en) * 2000-11-29 2002-06-11 Eli Lilly And Company 1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl)piperazine and pharmaceutically acceptable salts and solvates thereof and their use in the treatment of incontinence
WO2003000664A1 (de) * 2001-06-22 2003-01-03 Bayer Aktiengesellschaft Uracilderivative und ihre verwendung bei der behandlung bakterieller erkrankungen
US20050058696A1 (en) * 2003-09-12 2005-03-17 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
MXPA06002716A (es) 2003-09-12 2006-06-06 Allergan Inc Metodos y composiciones para el tratamiento de dolor y otras condiciones mediadas por adrenergicos de alfa-2.
US20050059744A1 (en) * 2003-09-12 2005-03-17 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
US20060264442A1 (en) * 2005-05-18 2006-11-23 Allergan, Inc. Methods for the treatment of ocular and neurodegenerative conditions in a mammal
CN101200451B (zh) * 2006-12-15 2010-12-15 重庆药友制药有限责任公司 一种盐酸乌拉地尔的制备方法
CN102295607B (zh) * 2011-06-16 2013-04-17 郑州大学 乌拉地尔的逆相转移催化制备方法
KR102638538B1 (ko) 2021-12-28 2024-02-20 주식회사 한서켐 우라피딜 제조 중간체의 제조방법
CN115477616A (zh) * 2022-09-27 2022-12-16 河北广祥制药有限公司 一种乌拉地尔杂质的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2567651A (en) * 1951-09-11 J-dialkyl-g-amino-l

Also Published As

Publication number Publication date
FI54479B (fi) 1978-08-31
DK124031B (da) 1972-09-04
BE755015A (fr) 1971-02-01
HK23678A (en) 1978-05-12
CH551990A (de) 1974-07-31
YU207670A (en) 1982-02-25
FR2073300B1 (no) 1974-02-01
FI54479C (fi) 1978-12-11
ES382842A1 (es) 1973-02-16
FR2073300A1 (no) 1971-10-01
SE386448B (sv) 1976-08-09
US4067982A (en) 1978-01-10
YU36518B (en) 1984-02-29
NL7012364A (no) 1971-02-23
IL35121A0 (en) 1970-10-30
IE35177L (en) 1971-02-20
HU163664B (no) 1973-10-27
BR6915466D0 (pt) 1973-05-15
IL35121A (en) 1974-03-14
US3957786A (en) 1976-05-18
NL155014B (nl) 1977-11-15
BG17585A3 (no) 1973-11-10
IE35177B1 (en) 1975-12-10
LU61527A1 (no) 1971-06-22
DE1942405B2 (de) 1973-10-31
AT302359B (de) 1972-10-10
NO129148B (no) 1974-03-04
SU399130A3 (no) 1973-09-27
ZA705729B (en) 1972-03-29
BG17796A3 (no) 1973-12-25
GB1309324A (en) 1973-03-07
CH582173A5 (no) 1976-11-30
DE1942405A1 (de) 1971-09-16
SU363248A3 (no) 1972-12-30
BG17795A3 (no) 1973-12-25
CA956944A (en) 1974-10-29
YU203979A (en) 1982-02-25
AT318651B (de) 1974-11-11
DE1942405C3 (de) 1974-05-30

Similar Documents

Publication Publication Date Title
YU294570A (en) Process for preparing delta-alkylamino-propiophenones
YU36509B (en) Process for obtaining aryl substituted piperazinylalkylamino-uraci, - uracilethers and - uracilthioethers
YU198170A (en) Process for preparing novel beta-aryl-2-aminoalkoxy-styrenes
YU254475A (en) Process for preparing novel 1-phenoxy-2-hydroxy-3-cycloalkyl-aminopropanes
YU35868B (en) Process for preparing naphthylalkylamines
YU238570A (en) Process for obtaining amino-alshols
YU33975B (en) Process for preparing bufatrienolide-rhamnoside-acylates
YU201378A (en) Process for obtaining 3-amino-delta2-pyrazoline
YU78170A (en) Process for obtaining novel dimethylaminopropylthiocarbamates
YU137270A (en) Process for preparing thiamphenicol-glycinate acetylcysteinate
YU34027B (en) Process for preparing novel substituted o-anilino-phenethyl-alcohols
YU184970A (en) Process for obtaining substituted bis-carbamates
YU36371B (en) Process for obtaining substituted phenyl-carbamates
YU144670A (en) Process for preparing substituted shloroacylanilides
YU188170A (en) Process for preparing 5-hydroxy-or 6-hydroxy-isoquinuclidines
YU201270A (en) Process for preparing phenyl-3-tert.-butyl-5-oxadiazolone-2
YU183570A (en) Process for preparing 3-chloro-4-n-and-iso-propoxy-ureas
YU140970A (en) Process for preparing novel substituted 5-nitro-2-furfurylidene-amino-oxazolidinones
YU39145B (en) Process for obtaining venzofuranyl compounds
KR780000173B1 (en) Process for producting -aryl-2aminoalkoxy-styrole
KR780000171B1 (en) Process for producting-aryl-2aminoalkoxy-styrole
YU279769A (en) Process for obtaining penicillins
YU166270A (en) Process for obtaining bis-alkanolamine derivatives
CS194181B2 (en) Process for preparing beta-anilino-alpha-benzyl-acrylonitriles
YU167369A (en) Process for preparing 9delta-fluoro-16-methylene-prednisolone-21-acetate